Because of the pleiotropic role of the RAS in multiple physiological processes, the MAS1‐targeting saRNAs developed in this study may also be extended to treat other diseases, such as cardiovascular[13a] or COVID‐19‐associated diseases. This evidence concerns the gene MAS1 and COVID-19.